Eat Just CEO: Large-scale cultivated meat production requires a new operating model

Eat Just is working on new CRISPR-enabled cell lines for cultivated meat it claims will increase efficiencies as it refines its models for profitable large-scale production.

The firm has revised plans to build a large-scale US facility deploying ten 250,000-L bioreactors and says it is “not attempting to raise money for a large-scale cultivated meat facility right now.” Instead, it is focusing on process development at its plant in Alameda, California, and is working on new cell lines it claims will enable more efficient large-scale production.

The firm has not sold any cultivated chicken to US consumers following a small-scale test last summer at a restaurant run by Chef José Andrés, but will keep selling the product in Singapore albeit on a tiny scale, CEO Josh Tetrick told AgFunderNews: “At some point in the future, this site [in Alameda] may produce commercially to get consumer feedback, but it would be on a very small scale.”